Associated Papers
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS.
Wixner J et al.
Cardiology and Therapy, 2025
Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Garcia-Pavia P et al.
Journal of Cardiac Failure, 2025
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Gentile L et al.
Orphanet Journal of Rare Diseases, 2023
37946256 (PubMed )
Supplement: 13023_2023_2962_MOESM1_ESM.docx
Select a paper to view details